Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Progestins and hemostasis]

A E Schindler1

  • 1Zentrum für Frauenheilkunde, Universitätsklinikum Essen.

Zentralblatt Fur Gynakologie
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Progesterone and progestins do not significantly alter the hemostatic system, even at high oncological doses. These findings suggest they do not critically impact hemostasis disturbances in cancer patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progestogens and immunology.

Best practice & research. Clinical obstetrics & gynaecology·2019
Same author

Operation, hormone therapy and recovery of the patients with severe forms of adenomyosis.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2018
Same author

Managing immunity in resistant cancer patients correlates to survival: results and discussion of a pilot study.

Hormone molecular biology and clinical investigation·2015
Same author

A pilot study to determine whether progestogen supplementation using dydrogesterone during the first trimester will reduce the incidence of gestational hypertension in primigravidae.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2014
Same author

Implementation of certified endometriosis centers: 5-year experience in German-speaking Europe.

Gynecologic and obstetric investigation·2013
Same author

Non-contraceptive benefits of hormonal contraceptives.

Minerva ginecologica·2010
Same journal

About 150 births naturally after previous Caesarean section.

Zentralblatt fur Gynakologie·2010
Same journal

About lutein cysts found in hydrops foetus et placentae.

Zentralblatt fur Gynakologie·2010
Same journal

The potencies of the burner epithelium, especially a tendency to form serous epitrel, squamous and mucosal epithelium.

Zentralblatt fur Gynakologie·2010
Same journal

Two double birth defects causing obstetric difficulties.

Zentralblatt fur Gynakologie·2010
Same journal

The uterine size and fundus level in the first part of pregnancy.

Zentralblatt fur Gynakologie·2010
Same journal

The crossbar interposition.

Zentralblatt fur Gynakologie·2010
See all related articles

Area of Science:

  • Endocrinology
  • Hematology
  • Oncology

Context:

  • Progesterone and progestins are widely used therapeutically.
  • Cancer patients often exhibit an activated hemostatic system.
  • Understanding the impact of progestins on hemostasis is crucial for patient safety.

Purpose:

  • To evaluate the effects of progesterone and progestins on the hemostatic system.
  • To determine if these agents exacerbate hemostasis disturbances in cancer patients.

Summary:

  • Progesterone and progestins did not induce significant changes in the hemostatic system parameters.
  • Both oral and parenteral administration showed no decisive action on hemostasis.
  • High-dose oncological therapy with progestins did not demonstrate remarkable negative effects on the already activated hemostatic system in cancer patients.

Related Experiment Videos

Impact:

  • These findings suggest that progesterone and progestins can be safely used without critically compromising hemostasis.
  • Provides reassurance for clinicians regarding the use of progestins in cancer patients with potential hemostatic abnormalities.